Biogen reported $9.74B in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
ALKERMES ALKS:US 1.05B 31.16M
Amgen AMGN:US $ 19322M 802M
Bayer BAYN:GR 39.55B 1.3B
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Gilead Sciences GILD:US $ 13705M 1076M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Intra Cellular Therapies ITCI:US $ 789.21M 59.14M
Marinus Pharmaceuticals MRNS:US $ 101.09M 33.98M
Moderna Inc MRNA:US 13.56B 2.79B
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
YTE INCY:US $ 3625.84M 337.75M